Literature DB >> 11787423

[Cryptosporidium parvum: functional study of the intestinal malabsorption syndrome].

L Barbot1, A Topouchian, C Capet, D Magne, J F Huneau, N Kapel, J G Gobert.   

Abstract

Cryptosporidiosis is an important cause of diarrhea associated with growth retardation in children and severe malnutrition in immunocompromised patients. The pathophysiology is poorly understood. In the suckling rat model, we show that C. parvum infection impairs net electrogenic transport across the ileal mucosa without involvement of prostaglandins, as well as trans- and paracellular permeability and leucine and glutamate absorption. These results provide evidence for the development of an intestinal malabsorptive syndrome during cryptosporidiosis. Unspecific process such as villous atrophy and inflammatory cytokines secretion should be regarded as possible mediators of this syndrome. However, specific mechanisms have to be considered since C. parvum induces a rearrangement of the host enterocyte cytoskeleton which might impaired intracellular trafficking thus reducing the membrane expression of nutrient transporters. Infection and malnutrition are known to be tightly associated, making each other worse. As no specific efficient therapy exists, cryptosporidiosis-induced malnutrition must be taken into account when establishing therapeutic scheme.

Entities:  

Mesh:

Year:  2001        PMID: 11787423

Source DB:  PubMed          Journal:  Ann Pharm Fr        ISSN: 0003-4509


  2 in total

1.  Regulation of the oligopeptide transporter, PEPT-1, in DSS-induced rat colitis.

Authors:  Genia Radeva; Marion Buyse; Patrick Hindlet; Benjamin Beaufils; Francine Walker; André Bado; Robert Farinotti
Journal:  Dig Dis Sci       Date:  2007-03-20       Impact factor: 3.487

2.  Intestinal parasitic infections in HIV infected and non-infected patients in a low HIV prevalence region, West-Cameroon.

Authors:  Céline Nguefeu Nkenfou; Christelle Tafou Nana; Vincent Khan Payne
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.